Todd Hankinson
Concepts (470)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniopharyngioma | 23 | 2025 | 78 | 8.770 |
Why?
| | Pituitary Neoplasms | 20 | 2025 | 195 | 6.800 |
Why?
| | Hydrocephalus | 20 | 2026 | 110 | 4.130 |
Why?
| | Arnold-Chiari Malformation | 14 | 2026 | 29 | 3.620 |
Why?
| | Brain Neoplasms | 29 | 2025 | 1300 | 3.370 |
Why?
| | Neurosurgical Procedures | 14 | 2024 | 205 | 3.220 |
Why?
| | Ventriculoperitoneal Shunt | 12 | 2026 | 41 | 1.960 |
Why?
| | Magnetic Resonance Imaging | 23 | 2026 | 3798 | 1.900 |
Why?
| | Brain Stem Neoplasms | 5 | 2016 | 84 | 1.750 |
Why?
| | Ganglioglioma | 5 | 2025 | 35 | 1.700 |
Why?
| | Decompression, Surgical | 10 | 2026 | 116 | 1.660 |
Why?
| | Child | 95 | 2026 | 22725 | 1.610 |
Why?
| | Atlanto-Axial Joint | 7 | 2020 | 13 | 1.580 |
Why?
| | Ependymoma | 11 | 2025 | 170 | 1.540 |
Why?
| | Joint Instability | 7 | 2020 | 171 | 1.540 |
Why?
| | Glioma | 7 | 2025 | 425 | 1.500 |
Why?
| | Cerebrospinal Fluid Shunts | 11 | 2026 | 32 | 1.420 |
Why?
| | Spinal Injuries | 4 | 2022 | 58 | 1.370 |
Why?
| | Infratentorial Neoplasms | 8 | 2025 | 64 | 1.350 |
Why?
| | Spinal Fusion | 9 | 2024 | 260 | 1.280 |
Why?
| | Dura Mater | 4 | 2026 | 35 | 1.250 |
Why?
| | Child, Preschool | 49 | 2026 | 11737 | 1.230 |
Why?
| | Syringomyelia | 6 | 2026 | 12 | 1.200 |
Why?
| | Pons | 4 | 2016 | 29 | 1.130 |
Why?
| | Occipital Bone | 5 | 2024 | 18 | 1.100 |
Why?
| | Cervical Vertebrae | 10 | 2026 | 150 | 1.080 |
Why?
| | Cervical Atlas | 3 | 2024 | 4 | 1.070 |
Why?
| | Xanthomatosis | 2 | 2017 | 8 | 1.050 |
Why?
| | Sella Turcica | 2 | 2017 | 17 | 1.050 |
Why?
| | Ventriculostomy | 9 | 2026 | 24 | 1.050 |
Why?
| | Infant | 39 | 2026 | 9981 | 1.030 |
Why?
| | Humans | 143 | 2026 | 143560 | 0.980 |
Why?
| | Neurosurgery | 4 | 2025 | 42 | 0.940 |
Why?
| | Tomography, X-Ray Computed | 11 | 2022 | 2779 | 0.910 |
Why?
| | Neuroendoscopy | 6 | 2025 | 24 | 0.900 |
Why?
| | Postoperative Complications | 15 | 2026 | 2887 | 0.840 |
Why?
| | Infant, Newborn | 20 | 2026 | 6366 | 0.830 |
Why?
| | Adolescent | 50 | 2026 | 22481 | 0.810 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2023 | 5 | 0.810 |
Why?
| | Machine Learning | 5 | 2026 | 574 | 0.810 |
Why?
| | Neck Injuries | 1 | 2022 | 21 | 0.750 |
Why?
| | Third Ventricle | 5 | 2025 | 15 | 0.750 |
Why?
| | Neural Tube Defects | 4 | 2019 | 65 | 0.740 |
Why?
| | Male | 75 | 2026 | 71500 | 0.730 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 772 | 0.730 |
Why?
| | Neuroprotection | 1 | 2022 | 45 | 0.710 |
Why?
| | Cellular Senescence | 1 | 2024 | 227 | 0.710 |
Why?
| | SEER Program | 4 | 2018 | 220 | 0.690 |
Why?
| | Female | 76 | 2026 | 77251 | 0.670 |
Why?
| | Retrospective Studies | 36 | 2026 | 16741 | 0.650 |
Why?
| | Transcriptome | 8 | 2025 | 1029 | 0.640 |
Why?
| | Reoperation | 7 | 2026 | 605 | 0.640 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 92 | 0.620 |
Why?
| | Pediatrics | 4 | 2026 | 1124 | 0.610 |
Why?
| | Down Syndrome | 2 | 2020 | 514 | 0.600 |
Why?
| | Perioperative Care | 2 | 2026 | 234 | 0.580 |
Why?
| | Brain Injuries, Traumatic | 3 | 2026 | 432 | 0.570 |
Why?
| | Infant, Premature | 2 | 2026 | 608 | 0.560 |
Why?
| | Atlanto-Occipital Joint | 3 | 2024 | 4 | 0.560 |
Why?
| | Treatment Outcome | 28 | 2026 | 11365 | 0.540 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2024 | 1095 | 0.530 |
Why?
| | Pituitary Diseases | 1 | 2017 | 20 | 0.520 |
Why?
| | Meningioma | 1 | 2018 | 89 | 0.510 |
Why?
| | Axis, Cervical Vertebra | 2 | 2022 | 7 | 0.510 |
Why?
| | Decision Support Systems, Clinical | 3 | 2026 | 270 | 0.510 |
Why?
| | Central Nervous System Neoplasms | 2 | 2019 | 172 | 0.510 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 97 | 0.510 |
Why?
| | Intracranial Hemorrhages | 2 | 2020 | 99 | 0.480 |
Why?
| | Skull | 1 | 2017 | 152 | 0.480 |
Why?
| | Cerebral Ventricles | 2 | 2022 | 54 | 0.480 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 18 | 0.470 |
Why?
| | Ketorolac | 1 | 2015 | 25 | 0.460 |
Why?
| | EGF Family of Proteins | 1 | 2015 | 17 | 0.460 |
Why?
| | Receptor, EphA2 | 1 | 2015 | 17 | 0.460 |
Why?
| | ErbB Receptors | 2 | 2016 | 617 | 0.460 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2025 | 230 | 0.450 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2015 | 23 | 0.450 |
Why?
| | Receptor, ErbB-3 | 1 | 2015 | 46 | 0.450 |
Why?
| | Temporal Lobe | 1 | 2015 | 104 | 0.450 |
Why?
| | Neocortex | 2 | 2025 | 44 | 0.450 |
Why?
| | Choroid Plexus Neoplasms | 1 | 2014 | 8 | 0.440 |
Why?
| | src-Family Kinases | 1 | 2015 | 96 | 0.430 |
Why?
| | Meningomyelocele | 3 | 2026 | 62 | 0.430 |
Why?
| | Data Collection | 2 | 2014 | 655 | 0.410 |
Why?
| | Professional Practice | 1 | 2014 | 62 | 0.410 |
Why?
| | Neurosurgeons | 3 | 2025 | 17 | 0.410 |
Why?
| | Delayed Diagnosis | 2 | 2024 | 91 | 0.400 |
Why?
| | Quality of Life | 6 | 2026 | 3080 | 0.390 |
Why?
| | Spinal Cord Injuries | 3 | 2024 | 238 | 0.390 |
Why?
| | Scoliosis | 3 | 2024 | 222 | 0.380 |
Why?
| | Moyamoya Disease | 2 | 2014 | 21 | 0.380 |
Why?
| | Young Adult | 17 | 2021 | 13972 | 0.380 |
Why?
| | Neurology | 1 | 2014 | 113 | 0.380 |
Why?
| | Intracranial Pressure | 2 | 2026 | 61 | 0.370 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 352 | 0.370 |
Why?
| | Urethral Diseases | 1 | 2011 | 19 | 0.360 |
Why?
| | Foreign-Body Migration | 1 | 2011 | 32 | 0.360 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 372 | 0.350 |
Why?
| | Societies, Medical | 2 | 2025 | 873 | 0.350 |
Why?
| | Genomics | 1 | 2016 | 831 | 0.340 |
Why?
| | Intracranial Hypertension | 2 | 2010 | 41 | 0.340 |
Why?
| | Observer Variation | 2 | 2025 | 361 | 0.340 |
Why?
| | Brain Injuries | 1 | 2016 | 506 | 0.340 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 732 | 0.330 |
Why?
| | Epilepsy | 2 | 2025 | 372 | 0.330 |
Why?
| | Cranial Sutures | 1 | 2010 | 12 | 0.330 |
Why?
| | Odontoid Process | 1 | 2010 | 4 | 0.330 |
Why?
| | Cephalometry | 1 | 2010 | 31 | 0.330 |
Why?
| | Craniotomy | 2 | 2008 | 82 | 0.330 |
Why?
| | Artificial Intelligence | 2 | 2025 | 365 | 0.320 |
Why?
| | Esthetics | 1 | 2010 | 47 | 0.320 |
Why?
| | Internal Fixators | 1 | 2010 | 36 | 0.310 |
Why?
| | Spinal Diseases | 1 | 2010 | 51 | 0.310 |
Why?
| | Craniosynostoses | 1 | 2010 | 61 | 0.310 |
Why?
| | Brain Stem | 1 | 2010 | 96 | 0.310 |
Why?
| | Biomarkers, Tumor | 3 | 2024 | 1282 | 0.310 |
Why?
| | Urinary Bladder | 1 | 2011 | 195 | 0.300 |
Why?
| | MAP Kinase Signaling System | 2 | 2024 | 325 | 0.300 |
Why?
| | Follow-Up Studies | 10 | 2026 | 5308 | 0.300 |
Why?
| | Patient Discharge | 1 | 2016 | 923 | 0.300 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1487 | 0.300 |
Why?
| | Surgeons | 1 | 2014 | 336 | 0.300 |
Why?
| | Anemia, Sickle Cell | 2 | 2014 | 280 | 0.290 |
Why?
| | Glomus Tumor | 1 | 2008 | 2 | 0.280 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 77 | 0.280 |
Why?
| | Neuroimaging | 3 | 2020 | 282 | 0.280 |
Why?
| | Orbital Neoplasms | 1 | 2008 | 26 | 0.280 |
Why?
| | Insurance, Liability | 1 | 2008 | 9 | 0.280 |
Why?
| | Cerebral Revascularization | 1 | 2008 | 22 | 0.280 |
Why?
| | Brain | 5 | 2023 | 2892 | 0.280 |
Why?
| | RNA, Messenger | 2 | 2017 | 2852 | 0.270 |
Why?
| | Pyramidal Cells | 2 | 2025 | 79 | 0.270 |
Why?
| | Surgical Wound Infection | 3 | 2022 | 328 | 0.270 |
Why?
| | Medically Underserved Area | 1 | 2008 | 101 | 0.260 |
Why?
| | Adult | 20 | 2025 | 40013 | 0.260 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 263 | 0.260 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 233 | 0.250 |
Why?
| | Granuloma | 2 | 2017 | 97 | 0.250 |
Why?
| | Surgical Flaps | 1 | 2008 | 145 | 0.250 |
Why?
| | Astrocytoma | 2 | 2025 | 130 | 0.250 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 724 | 0.250 |
Why?
| | KCNQ2 Potassium Channel | 1 | 2025 | 15 | 0.240 |
Why?
| | 4-Aminopyridine | 1 | 2025 | 30 | 0.240 |
Why?
| | Potassium Channel Blockers | 1 | 2025 | 46 | 0.240 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 347 | 0.230 |
Why?
| | Autophagy | 2 | 2019 | 287 | 0.230 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2026 | 41 | 0.230 |
Why?
| | Prognosis | 7 | 2019 | 4152 | 0.230 |
Why?
| | Cranial Fossa, Posterior | 2 | 2026 | 20 | 0.230 |
Why?
| | Subdural Effusion | 1 | 2024 | 4 | 0.220 |
Why?
| | Interdisciplinary Communication | 1 | 2026 | 198 | 0.220 |
Why?
| | Equipment Failure | 2 | 2025 | 112 | 0.220 |
Why?
| | Infant, Premature, Diseases | 1 | 2026 | 108 | 0.220 |
Why?
| | United States | 8 | 2025 | 15553 | 0.220 |
Why?
| | Radiation Injuries | 2 | 2018 | 149 | 0.220 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 121 | 0.210 |
Why?
| | Macrophage Activation | 1 | 2025 | 192 | 0.210 |
Why?
| | Adrenoleukodystrophy | 1 | 2024 | 9 | 0.210 |
Why?
| | Neuronavigation | 1 | 2024 | 8 | 0.210 |
Why?
| | Computational Biology | 3 | 2025 | 677 | 0.210 |
Why?
| | Clonal Evolution | 1 | 2024 | 47 | 0.210 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2024 | 31 | 0.210 |
Why?
| | Reproducibility of Results | 2 | 2025 | 3380 | 0.210 |
Why?
| | Phagocytosis | 1 | 2025 | 291 | 0.200 |
Why?
| | Drainage | 1 | 2024 | 182 | 0.200 |
Why?
| | Microarray Analysis | 4 | 2017 | 118 | 0.200 |
Why?
| | Tumor Burden | 1 | 2024 | 319 | 0.200 |
Why?
| | Combined Modality Therapy | 3 | 2019 | 1252 | 0.200 |
Why?
| | Cohort Studies | 8 | 2024 | 5891 | 0.190 |
Why?
| | Brain Concussion | 2 | 2022 | 595 | 0.190 |
Why?
| | Sensitivity and Specificity | 2 | 2025 | 1984 | 0.190 |
Why?
| | Attitude of Health Personnel | 1 | 2011 | 1207 | 0.190 |
Why?
| | Pineal Gland | 1 | 2022 | 15 | 0.190 |
Why?
| | Pinealoma | 1 | 2022 | 9 | 0.190 |
Why?
| | Nerve Net | 1 | 2025 | 276 | 0.190 |
Why?
| | Germinoma | 1 | 2022 | 10 | 0.190 |
Why?
| | Contrast Media | 1 | 2025 | 479 | 0.190 |
Why?
| | Cysts | 1 | 2023 | 114 | 0.190 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.180 |
Why?
| | Nuclear Proteins | 2 | 2025 | 749 | 0.180 |
Why?
| | Hedgehog Proteins | 2 | 2022 | 200 | 0.180 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 18 | 0.180 |
Why?
| | Developing Countries | 1 | 2024 | 308 | 0.180 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 197 | 0.180 |
Why?
| | Software | 2 | 2025 | 687 | 0.180 |
Why?
| | Spine | 1 | 2023 | 179 | 0.180 |
Why?
| | Radiation | 1 | 2021 | 24 | 0.180 |
Why?
| | beta Catenin | 2 | 2024 | 256 | 0.170 |
Why?
| | Endoscopy | 2 | 2015 | 329 | 0.170 |
Why?
| | Chromosome Aberrations | 2 | 2023 | 164 | 0.170 |
Why?
| | Traction | 1 | 2021 | 19 | 0.170 |
Why?
| | Chromatin | 1 | 2025 | 554 | 0.170 |
Why?
| | Cerebral Hemorrhage | 1 | 2022 | 118 | 0.170 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3611 | 0.170 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 921 | 0.170 |
Why?
| | Disease Progression | 3 | 2024 | 2856 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 539 | 0.160 |
Why?
| | Patient Care Team | 1 | 2026 | 690 | 0.160 |
Why?
| | Preoperative Period | 1 | 2020 | 145 | 0.160 |
Why?
| | Delphi Technique | 4 | 2025 | 326 | 0.160 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 14 | 0.160 |
Why?
| | Sports | 1 | 2022 | 222 | 0.160 |
Why?
| | Benchmarking | 1 | 2021 | 183 | 0.150 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 80 | 0.150 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2019 | 7 | 0.150 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 179 | 0.150 |
Why?
| | Databases, Factual | 2 | 2016 | 1465 | 0.150 |
Why?
| | Medulloblastoma | 1 | 2022 | 218 | 0.150 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 11 | 0.150 |
Why?
| | Spinal Cord Diseases | 1 | 2019 | 44 | 0.150 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.150 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1794 | 0.150 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2019 | 38 | 0.150 |
Why?
| | Biomedical Research | 1 | 2025 | 699 | 0.150 |
Why?
| | Hematoma, Subdural | 1 | 2018 | 20 | 0.150 |
Why?
| | Middle Aged | 12 | 2020 | 35342 | 0.140 |
Why?
| | Neoplasm Grading | 2 | 2021 | 312 | 0.140 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1510 | 0.140 |
Why?
| | Cerebellum | 1 | 2020 | 222 | 0.140 |
Why?
| | Craniospinal Irradiation | 1 | 2018 | 5 | 0.140 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 10 | 0.140 |
Why?
| | Spinal Curvatures | 1 | 2018 | 5 | 0.140 |
Why?
| | Specialties, Surgical | 1 | 2019 | 80 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 691 | 0.140 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 234 | 0.140 |
Why?
| | Skull Neoplasms | 1 | 2017 | 21 | 0.140 |
Why?
| | Bone Transplantation | 1 | 2018 | 90 | 0.140 |
Why?
| | Phenotype | 2 | 2024 | 3211 | 0.140 |
Why?
| | Stromal Cells | 1 | 2018 | 128 | 0.140 |
Why?
| | Bone Resorption | 1 | 2018 | 85 | 0.130 |
Why?
| | Cyst Fluid | 1 | 2017 | 21 | 0.130 |
Why?
| | Risk Factors | 7 | 2022 | 10644 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 213 | 0.130 |
Why?
| | Hypophysitis | 1 | 2017 | 3 | 0.130 |
Why?
| | Macrophages | 1 | 2025 | 1506 | 0.130 |
Why?
| | Fetus | 1 | 2022 | 806 | 0.130 |
Why?
| | Re-Irradiation | 1 | 2016 | 9 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 354 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2020 | 586 | 0.130 |
Why?
| | Chloroquine | 1 | 2017 | 54 | 0.130 |
Why?
| | Survival Analysis | 2 | 2023 | 1332 | 0.130 |
Why?
| | Patient Admission | 1 | 2018 | 203 | 0.130 |
Why?
| | Sarcoma, Ewing | 1 | 2017 | 100 | 0.120 |
Why?
| | Nurses | 1 | 2019 | 188 | 0.120 |
Why?
| | Aged, 80 and over | 4 | 2018 | 8072 | 0.120 |
Why?
| | Consensus | 3 | 2025 | 550 | 0.120 |
Why?
| | Glioblastoma | 2 | 2010 | 350 | 0.120 |
Why?
| | Organ Size | 1 | 2017 | 481 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2195 | 0.120 |
Why?
| | Algorithms | 2 | 2022 | 1813 | 0.120 |
Why?
| | Age Factors | 3 | 2020 | 3328 | 0.120 |
Why?
| | Animals | 8 | 2025 | 38010 | 0.120 |
Why?
| | Blood Transfusion | 1 | 2019 | 401 | 0.120 |
Why?
| | Aged | 7 | 2019 | 25322 | 0.120 |
Why?
| | Athletic Injuries | 1 | 2022 | 531 | 0.120 |
Why?
| | Cetirizine | 1 | 2015 | 2 | 0.120 |
Why?
| | Accidents, Traffic | 2 | 2014 | 192 | 0.120 |
Why?
| | Ambrosia | 1 | 2015 | 7 | 0.120 |
Why?
| | Nasal Sprays | 1 | 2015 | 6 | 0.120 |
Why?
| | Registries | 4 | 2026 | 2238 | 0.120 |
Why?
| | Amphiregulin | 1 | 2015 | 26 | 0.110 |
Why?
| | Fluticasone | 1 | 2015 | 56 | 0.110 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2015 | 28 | 0.110 |
Why?
| | Cataract | 1 | 2018 | 235 | 0.110 |
Why?
| | Cytokines | 3 | 2018 | 2097 | 0.110 |
Why?
| | Radiography | 4 | 2023 | 846 | 0.110 |
Why?
| | Length of Stay | 2 | 2019 | 1279 | 0.110 |
Why?
| | Glasgow Coma Scale | 3 | 2026 | 214 | 0.110 |
Why?
| | Cerebral Veins | 1 | 2014 | 16 | 0.100 |
Why?
| | Logistic Models | 3 | 2019 | 2107 | 0.100 |
Why?
| | Chromosomes | 2 | 2024 | 107 | 0.100 |
Why?
| | Mice | 7 | 2025 | 18378 | 0.100 |
Why?
| | Mutation | 5 | 2025 | 4053 | 0.100 |
Why?
| | Disease-Free Survival | 1 | 2015 | 720 | 0.100 |
Why?
| | Arachnoid Cysts | 1 | 2013 | 10 | 0.100 |
Why?
| | Central Nervous System Cysts | 1 | 2013 | 13 | 0.100 |
Why?
| | Indoles | 1 | 2017 | 479 | 0.100 |
Why?
| | Carcinoma | 1 | 2014 | 230 | 0.100 |
Why?
| | Survival Rate | 2 | 2019 | 2003 | 0.090 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 11 | 0.090 |
Why?
| | Sulfonamides | 1 | 2017 | 582 | 0.090 |
Why?
| | Neuropsychological Tests | 2 | 2023 | 1099 | 0.090 |
Why?
| | Seasons | 1 | 2015 | 556 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 3 | 2017 | 569 | 0.090 |
Why?
| | Cerebral Angiography | 2 | 2014 | 117 | 0.090 |
Why?
| | Up-Regulation | 1 | 2015 | 863 | 0.090 |
Why?
| | Action Potentials | 2 | 2025 | 513 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4522 | 0.090 |
Why?
| | Ischemic Attack, Transient | 2 | 2014 | 71 | 0.090 |
Why?
| | Urethra | 1 | 2011 | 56 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1292 | 0.090 |
Why?
| | Lymphangioma, Cystic | 1 | 2011 | 5 | 0.090 |
Why?
| | Treatment Failure | 2 | 2025 | 357 | 0.090 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 59 | 0.090 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 875 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1906 | 0.090 |
Why?
| | Umbilicus | 1 | 2011 | 19 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 2270 | 0.090 |
Why?
| | Neurologic Examination | 1 | 2011 | 127 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2025 | 974 | 0.080 |
Why?
| | Brachial Plexus | 1 | 2011 | 34 | 0.080 |
Why?
| | Monitoring, Physiologic | 2 | 2026 | 289 | 0.080 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2010 | 6 | 0.080 |
Why?
| | Signal Transduction | 2 | 2025 | 5214 | 0.080 |
Why?
| | Teratoma | 1 | 2011 | 121 | 0.080 |
Why?
| | Magnetic Resonance Angiography | 2 | 2014 | 251 | 0.080 |
Why?
| | Rhabdoid Tumor | 1 | 2011 | 104 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1505 | 0.080 |
Why?
| | Radiosurgery | 1 | 2014 | 391 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1362 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2025 | 2542 | 0.070 |
Why?
| | Skull Fracture, Depressed | 1 | 2008 | 1 | 0.070 |
Why?
| | Prospective Studies | 4 | 2026 | 7899 | 0.070 |
Why?
| | Head Injuries, Closed | 1 | 2008 | 49 | 0.070 |
Why?
| | Zygoma | 1 | 2008 | 7 | 0.070 |
Why?
| | Pia Mater | 1 | 2008 | 5 | 0.070 |
Why?
| | Topography, Medical | 1 | 2008 | 11 | 0.070 |
Why?
| | Computer Simulation | 3 | 2021 | 1028 | 0.070 |
Why?
| | Functional Laterality | 1 | 2009 | 243 | 0.070 |
Why?
| | Diagnosis, Differential | 2 | 2012 | 1504 | 0.070 |
Why?
| | Biopsy | 1 | 2011 | 1083 | 0.070 |
Why?
| | Temporal Arteries | 1 | 2008 | 44 | 0.070 |
Why?
| | Electronic Health Records | 1 | 2016 | 1163 | 0.070 |
Why?
| | Models, Anatomic | 1 | 2008 | 86 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 108 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2009 | 191 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 197 | 0.070 |
Why?
| | Paraganglioma | 1 | 2008 | 53 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 292 | 0.060 |
Why?
| | Diagnostic Imaging | 1 | 2010 | 333 | 0.060 |
Why?
| | Population Dynamics | 1 | 2008 | 156 | 0.060 |
Why?
| | Recurrence | 1 | 2010 | 1114 | 0.060 |
Why?
| | Choroid Plexus | 1 | 2026 | 6 | 0.060 |
Why?
| | Cognition Disorders | 1 | 2010 | 523 | 0.060 |
Why?
| | Forecasting | 1 | 2008 | 384 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 562 | 0.060 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 282 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 970 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 272 | 0.060 |
Why?
| | CD47 Antigen | 1 | 2025 | 43 | 0.060 |
Why?
| | Malformations of Cortical Development | 1 | 2025 | 14 | 0.060 |
Why?
| | Research Support as Topic | 1 | 2025 | 81 | 0.060 |
Why?
| | Cranial Fontanelles | 1 | 2024 | 4 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2026 | 3625 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1136 | 0.060 |
Why?
| | Seizures | 1 | 2008 | 454 | 0.050 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2023 | 13 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2024 | 217 | 0.050 |
Why?
| | Intelligence Tests | 1 | 2023 | 63 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 69 | 0.050 |
Why?
| | Stroke | 2 | 2014 | 1213 | 0.050 |
Why?
| | Spinal Cord | 1 | 2026 | 379 | 0.050 |
Why?
| | Heart Atria | 1 | 2024 | 146 | 0.050 |
Why?
| | Drug Resistant Epilepsy | 1 | 2025 | 116 | 0.050 |
Why?
| | Cranial Irradiation | 1 | 2023 | 84 | 0.050 |
Why?
| | Fluorouracil | 1 | 2024 | 210 | 0.050 |
Why?
| | Sex Factors | 1 | 2009 | 2092 | 0.050 |
Why?
| | Patients' Rooms | 1 | 2022 | 13 | 0.050 |
Why?
| | Abdomen | 1 | 2023 | 140 | 0.050 |
Why?
| | Narcotics | 1 | 2022 | 55 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 74 | 0.040 |
Why?
| | Gene Ontology | 1 | 2021 | 51 | 0.040 |
Why?
| | NF-kappa B | 1 | 2025 | 685 | 0.040 |
Why?
| | Vancomycin | 1 | 2022 | 94 | 0.040 |
Why?
| | Mass Screening | 1 | 2010 | 1334 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 389 | 0.040 |
Why?
| | Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 219 | 0.040 |
Why?
| | Transplants | 1 | 2021 | 39 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 183 | 0.040 |
Why?
| | Postoperative Care | 1 | 2022 | 281 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2021 | 197 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1831 | 0.040 |
Why?
| | Recovery of Function | 1 | 2024 | 702 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 502 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2021 | 284 | 0.040 |
Why?
| | Genes, APC | 1 | 2019 | 12 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 372 | 0.040 |
Why?
| | Aminopyridines | 1 | 2019 | 118 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2019 | 98 | 0.040 |
Why?
| | Athletes | 1 | 2022 | 419 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 112 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2013 | 1736 | 0.040 |
Why?
| | Benzamides | 1 | 2019 | 223 | 0.040 |
Why?
| | Surgical Wound | 1 | 2018 | 27 | 0.040 |
Why?
| | Critical Care Nursing | 1 | 2019 | 53 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 243 | 0.040 |
Why?
| | Odontogenesis | 1 | 2018 | 11 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 65 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 173 | 0.040 |
Why?
| | Laser Capture Microdissection | 1 | 2018 | 31 | 0.030 |
Why?
| | Weight Gain | 1 | 2022 | 550 | 0.030 |
Why?
| | Standard of Care | 1 | 2018 | 78 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 607 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 82 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2018 | 3006 | 0.030 |
Why?
| | Drug Approval | 1 | 2018 | 89 | 0.030 |
Why?
| | Receptors, HIV | 1 | 2017 | 25 | 0.030 |
Why?
| | Mucin-1 | 1 | 2017 | 21 | 0.030 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 33 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 383 | 0.030 |
Why?
| | Receptors, Interleukin-6 | 1 | 2017 | 46 | 0.030 |
Why?
| | Pituitary Gland | 1 | 2018 | 151 | 0.030 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 58 | 0.030 |
Why?
| | Heart-Assist Devices | 1 | 2003 | 572 | 0.030 |
Why?
| | Canada | 1 | 2018 | 433 | 0.030 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1524 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 114 | 0.030 |
Why?
| | Brain Diseases | 1 | 2018 | 151 | 0.030 |
Why?
| | Overweight | 1 | 2022 | 598 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 112 | 0.030 |
Why?
| | Blotting, Western | 1 | 2019 | 1223 | 0.030 |
Why?
| | Neuroglia | 1 | 2018 | 173 | 0.030 |
Why?
| | Prevalence | 2 | 2016 | 2830 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2003 | 726 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 512 | 0.030 |
Why?
| | Transcription Factors | 2 | 2017 | 1754 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 941 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 312 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 667 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 326 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2018 | 279 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 7153 | 0.030 |
Why?
| | Drug Synergism | 1 | 2017 | 370 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1668 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 524 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2019 | 868 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1192 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 447 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2086 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 252 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2016 | 277 | 0.030 |
Why?
| | Illinois | 1 | 2013 | 45 | 0.030 |
Why?
| | Chicago | 1 | 2013 | 66 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2429 | 0.020 |
Why?
| | Quality Improvement | 1 | 2022 | 1263 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6025 | 0.020 |
Why?
| | Necrosis | 1 | 2013 | 247 | 0.020 |
Why?
| | History, 19th Century | 1 | 2011 | 61 | 0.020 |
Why?
| | Qualitative Research | 1 | 2019 | 1563 | 0.020 |
Why?
| | SMARCB1 Protein | 1 | 2011 | 35 | 0.020 |
Why?
| | Germany | 1 | 2011 | 139 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2844 | 0.020 |
Why?
| | Arthritis, Juvenile | 1 | 2011 | 57 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2519 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2011 | 136 | 0.020 |
Why?
| | Abducens Nerve Diseases | 1 | 2010 | 12 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1557 | 0.020 |
Why?
| | History, 20th Century | 1 | 2011 | 327 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1235 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 351 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2010 | 56 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 415 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 22 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3041 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2009 | 434 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 246 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2881 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5743 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2177 | 0.010 |
Why?
| | New York | 1 | 2003 | 131 | 0.010 |
Why?
| | Shock, Cardiogenic | 1 | 2003 | 61 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2003 | 128 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3577 | 0.010 |
Why?
| | Stroke Volume | 1 | 2003 | 607 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2003 | 962 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2003 | 755 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2003 | 886 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 7031 | 0.010 |
Why?
| | Heart Failure | 1 | 2003 | 2131 | 0.000 |
Why?
|
|
Hankinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|